Impact of anti-CD20 monoclonal antibodies on serologic response to
Por um escritor misterioso
Descrição
CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies - ScienceDirect
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas
Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
JPM, Free Full-Text
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors - ScienceDirect
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
Vaccination and immunotherapies in neuroimmunological diseases
Frontiers Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients - ScienceDirect
The effects of type I and type II anti-CD20 mAb binding to CD20 on
de
por adulto (o preço varia de acordo com o tamanho do grupo)
